Amedeo Smart

Free Medical Literature Service


 

Amedeo

Arrhythmias

  Free Subscription

Articles published in
PLoS One
    January 2024
  1. JALALI R, Romaszko J, Draganska E, Gromadzinski L, et al
    Heat and cold stress increases the risk of paroxysmal supraventricular tachycardia.
    PLoS One. 2024;19:e0296412.
    >> Share

  2. SCHOLTEN M, Davidge J, Agvall B, Halling A, et al
    Comorbidities in heart failure patients that predict cardiovascular readmissions within 100 days-An observational study.
    PLoS One. 2024;19:e0296527.
    >> Share

  3. SINGH H, Shahid MZ, Harrison SL, Lane DA, et al
    Subclinical thyroid dysfunction and the risk of incident atrial fibrillation: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0296413.
    >> Share

  4. OWUSU-MENSAH A, Treat J, Bernardi J, Pfeiffer R, et al
    Identification and characterization of two novel KCNH2 mutations contributing to long QT syndrome.
    PLoS One. 2024;19:e0287206.
    >> Share

  5. SHAKIR M, Hassan SM, Adil U, Abidi SMA, et al
    Unveiling the silent threat of new onset atrial fibrillation in covid-19 hospitalized patients: A retrospective cohort study.
    PLoS One. 2024;19:e0291829.
    >> Share

  6. LIMCHAROEN S, Limprasert S, Boonmuang P, Pongchaidecha M, et al
    Does amiodarone impact on apixaban levels? The effect of amiodarone on apixaban level among Thai patients with non-valvular Atrial Fibrillation.
    PLoS One. 2024;19:e0295511.
    >> Share

  7. KAWAJI T, Bao B, Hojo S, Tezuka Y, et al
    Variation in the frozen lesion size according to the non-occluded application duration and technique for cryoballoon ablation.
    PLoS One. 2024;19:e0297263.
    >> Share

  8. INOUE N, Morikawa S, Ogane T, Hiramatsu T, et al
    Clinical value of the fibrosis-4 index in predicting mortality in patients with right ventricular pacing.
    PLoS One. 2024;19:e0294221.
    >> Share

  9. YASMIN F, Ali E, Moeed A, Zaidi F, et al
    Safety and efficacy of percutaneous Watchman 2.5 device versus Amplatzer Amulet for left atrial appendage closure in patients with non-valvular atrial fibrillation: A systematic review and study-level meta-analysis.
    PLoS One. 2024;19:e0295804.
    >> Share

  10. TEFERA M, Birhanu D, Mihretie A, Belete E, et al
    Magnitude of meconium stained amniotic fluid and associated factors among women who gave birth in North Shoa Zone hospitals, Amhara Region, Ethiopia 2022.
    PLoS One. 2024;19:e0297654.
    >> Share

  11. PHROMMINTIKUL A, Pongbangli N, Gunaparn S, Prasertwitayakij N, et al
    Association of the interatrial block and left atrial fibrosis in the patients without history of atrial fibrillation.
    PLoS One. 2024;19:e0297920.
    >> Share

  12. KASIM S, Amir Rudin PNF, Malek S, Aziz F, et al
    Data analytics approach for short- and long-term mortality prediction following acute non-ST-elevation myocardial infarction (NSTEMI) and Unstable Angina (UA) in Asians.
    PLoS One. 2024;19:e0298036.
    >> Share

  13. VECCHIARELLI E, Bentley RF, Connelly KA, Dorian P, et al
    Atrial fibrillation in middle-aged athletes: Impact on left atrial, ventricular and exercise performance.
    PLoS One. 2024;19:e0294367.
    >> Share

  14. CAMPBELL NG, Allen E, Evans R, Jamal Z, et al
    Impact of maintaining serum potassium concentration >/= 3.6mEq/L versus >/= 4.5mEq/L for 120 hours after isolated coronary artery bypass graft surgery on incidence of new onset atrial fibrillation: Protocol for a randomized non-inferiority trial.
    PLoS One. 2024;19:e0296525.
    >> Share

  15. IAMSHANOVA O, Hammerli AF, Ramaye E, Seljmani A, et al
    The dispensability of 14-3-3 proteins for the regulation of human cardiac sodium channel Nav1.5.
    PLoS One. 2024;19:e0298820.
    >> Share

  16. RUIGOMEZ A, Schink T, Voss A, Herings RMC, et al
    Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries.
    PLoS One. 2024;19:e0298596.
    >> Share

  17. MANDALA S, Rizal A, Adiwijaya, Nurmaini S, et al
    An improved method to detect arrhythmia using ensemble learning-based model in multi lead electrocardiogram (ECG).
    PLoS One. 2024;19:e0297551.
    >> Share

  18. MAURY P, Sanchis K, Djouadi K, Cariou E, et al
    Catheter ablation of atrial arrhythmias in cardiac amyloidosis: Impact on heart failure and mortality.
    PLoS One. 2024;19:e0301753.
    >> Share

  19. PENG M, Doshi A, Amos Y, Tsoref L, et al
    Does radiofrequency ablation procedural data improve the accuracy of identifying atrial fibrillation recurrence?
    PLoS One. 2024;19:e0300309.
    >> Share

    January 2023
  20. YUAN M, Lian H, Li P
    Spatiotemporal patterns of early afterdepolarizations underlying abnormal T-wave morphologies in a tissue model of the Purkinje-ventricular system.
    PLoS One. 2023;18:e0280267.
    >> Share

  21. LEE K, Lee SK, Lee J, Jeon BK, et al
    Protocol of BEYOND trial: Clinical BEnefit of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in rhYthm cONtrol of atrial fibrillation in patients with diabetes mellitus.
    PLoS One. 2023;18:e0280359.
    >> Share

  22. KAMALI R, Kwan E, Regouski M, Bunch TJ, et al
    Contribution of atrial myofiber architecture to atrial fibrillation.
    PLoS One. 2023;18:e0279974.
    >> Share

  23. KIM SK, Park JO, Park HA, Lee CA, et al
    Analyzing willingness for extracorporeal cardiopulmonary resuscitation in refractory ventricular fibrillation.
    PLoS One. 2023;18:e0281092.
    >> Share

  24. SUZUKI S, Yamashita T, Akao M, Atarashi H, et al
    Clinical phenotypes of older adults with non-valvular atrial fibrillation not treated with oral anticoagulants by hierarchical cluster analysis in the ANAFIE Registry.
    PLoS One. 2023;18:e0280753.
    >> Share

  25. AURELIUS T, Ken-Dror G, Sharma SD, Amlani S, et al
    Atrial fibrillation in UK South Asian hospitalized ischemic stroke patients: The BRAINS study.
    PLoS One. 2023;18:e0281014.
    >> Share

  26. WEI M, Wang P, Zhu X, Morishima M, et al
    Electrophysiological evaluation of an anticancer drug gemcitabine on cardiotoxicity revealing down-regulation and modification of the activation gating properties in the human rapid delayed rectifier potassium channel.
    PLoS One. 2023;18:e0280656.
    >> Share

  27. HERNANDEZ I, He M, Guo J, Tadrous M, et al
    COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: A nationwide analysis of claims data.
    PLoS One. 2023;18:e0281068.
    >> Share

  28. PONG T, Aparicio-Valenzuela J, Obafemi O, Cyr K, et al
    High-resolution spatiotemporal changes in dominant frequency and structural organization during persistent atrial fibrillation.
    PLoS One. 2023;18:e0271846.
    >> Share

  29. YORIKAWA F, Ishikawa J, Tamura Y, Murao Y, et al
    Determinants of depressive symptoms in older outpatients with cardiometabolic diseases in a Japanese frailty clinic: Importance of bidirectional association between depression and frailty.
    PLoS One. 2023;18:e0281465.
    >> Share

  30. GONZALEZ-MARTIN P, Sacco F, Butakoff C, Doste R, et al
    Ventricular anatomical complexity and sex differences impact predictions from electrophysiological computational models.
    PLoS One. 2023;18:e0263639.
    >> Share

  31. KRITTAYAPHONG R, Boonyapiphat T, Aroonsiriwattana S, Ngamjanyaporn P, et al
    Causes of death of patients with non-valvular atrial fibrillation in Asians.
    PLoS One. 2023;18:e0282455.
    >> Share

  32. MACHINO T, Aonuma K, Maruo K, Komatsu Y, et al
    Randomized crossover trial of 2-week Garment electrocardiogram with dry textile electrode to reveal instances of post-ablation recurrence of atrial fibrillation underdiagnosed during 24-hour Holter monitoring.
    PLoS One. 2023;18:e0281818.
    >> Share

  33. MORET C, Acosta-Isaac R, Mojal S, Corrochano M, et al
    Clinical outcomes in patients with atrial fibrillation treated with DOACs in a specialized anticoagulation center: Critical appraisal of real-world data.
    PLoS One. 2023;18:e0279297.
    >> Share

  34. CLEMENS DJ, Ye D, Zhou W, Kim CSJ, et al
    SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19.
    PLoS One. 2023;18:e0282151.
    >> Share

  35. GLEVA MJ, Sullivan J, Crawford TC, Walcott G, et al
    Defibrillation effectiveness and safety of the shock waveform used in a contemporary wearable cardioverter defibrillator: Results from animal and human studies.
    PLoS One. 2023;18:e0281340.
    >> Share

  36. ROSENSTROM S, Risom SS, Kallemose T, Dixen U, et al
    Clinical outcomes of a short-term family-focused intervention for patients with atrial fibrillation-A randomised clinical trial.
    PLoS One. 2023;18:e0282639.
    >> Share

  37. SERAFIM KR, Moreira DAR, da Costa PA, Habib RG, et al
    The accuracy of the Stroke Risk Analysis (SRA) system for predicting atrial fibrillation in patients in the postoperative period of myocardial revascularization.
    PLoS One. 2023;18:e0282565.
    >> Share

  38. HUANG K, Fan X, Jiang Y, Jin S, et al
    Integrative identification of hub genes in development of atrial fibrillation related stroke.
    PLoS One. 2023;18:e0283617.
    >> Share

  39. HARADA M, Okuzaki D, Yamauchi A, Ishikawa S, et al
    Circulating miR-20b-5p and miR-330-3p are novel biomarkers for progression of atrial fibrillation: Intracardiac/extracardiac plasma sample analysis by small RNA sequencing.
    PLoS One. 2023;18:e0283942.
    >> Share

  40. HAN KD, Hwang Y, Park SH
    Blood pressure status affects atrial fibrillation in diabetic end-stage renal disease.
    PLoS One. 2023;18:e0283875.
    >> Share

  41. HUA J, Chu B, Zou J, Jia J, et al
    ECG signal classification in wearable devices based on compressed domain.
    PLoS One. 2023;18:e0284008.
    >> Share

  42. SCHWARZWALD A, Fischer U, Seiffge D, Beyeler M, et al
    Impact of sex in stroke in the young.
    PLoS One. 2023;18:e0274722.
    >> Share

  43. HWANG HJ, Sohn IS, Jin ES, Bae YJ, et al
    Adherence and clinical outcomes for twice-daily versus once-daily dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: Is dosing frequency important?
    PLoS One. 2023;18:e0283478.
    >> Share

  44. JOUFFROY R, Ecollan P, Chollet-Xemard C, Prunet B, et al
    Evaluation of the effectiveness of potassium chloride in the management of out-of hospital cardiac arrest by refractory ventricular fibrillation: Study protocol of the POTACREH study.
    PLoS One. 2023;18:e0284429.
    >> Share

  45. SELBY R, Kaus L, Sealey F, Koo M, et al
    Quality of anticoagulant control and patient experience associated with long-term warfarin in Canadian patients with non-valvular atrial fibrillation: A multicentre, prospective study.
    PLoS One. 2023;18:e0284425.
    >> Share

  46. KHAN F, Yu X, Yuan Z, Rehman AU, et al
    ECG classification using 1-D convolutional deep residual neural network.
    PLoS One. 2023;18:e0284791.
    >> Share

  47. LIN CY, Chang TY, Hu YF, Hsieh YC, et al
    Epicardial electrical heterogeneity after amiodarone treatment increases vulnerability to ventricular arrhythmias under therapeutic hypothermia.
    PLoS One. 2023;18:e0282943.
    >> Share

  48. TAJIMA K, Yamakawa K, Kuwabara Y, Miyazaki C, et al
    Propofol anesthesia decreases the incidence of new-onset postoperative atrial fibrillation compared to desflurane in patients undergoing video-assisted thoracoscopic surgery: A retrospective single-center study.
    PLoS One. 2023;18:e0285120.
    >> Share

  49. DI DIEGO JM, Barajas-Martinez H, Cox R, Robinson VM, et al
    Mechanisms underlying the antiarrhythmic effect of ARumenamide-787 in experimental models of the J wave syndromes and hypothermia.
    PLoS One. 2023;18:e0281977.
    >> Share

  50. DELASNERIE H, Biendel C, Elbaz M, Mandel F, et al
    Hemodynamical consequences and tolerance of sustained ventricular tachycardia.
    PLoS One. 2023;18:e0285802.
    >> Share

  51. FIRTH C, Shamoun F, Apolinario M, Lim ES, et al
    Safety and mortality outcomes for direct oral anticoagulants in renal transplant recipients.
    PLoS One. 2023;18:e0285412.
    >> Share

  52. MISTRY S, Gouripeddi R, Reno CM, Abdelrahman S, et al
    Detecting hypoglycemia-induced electrocardiogram changes in a rodent model of type 1 diabetes using shape-based clustering.
    PLoS One. 2023;18:e0284622.
    >> Share

  53. KWAN JM, Arbune A, Henry ML, Hu R, et al
    Quantitative cardiovascular magnetic resonance findings and clinical risk factors predict cardiovascular outcomes in breast cancer patients.
    PLoS One. 2023;18:e0286364.
    >> Share

  54. LY TD, Sambale M, Klosener L, Traut P, et al
    Understanding of arthrofibrosis: New explorative insights into extracellular matrix remodeling of synovial fibroblasts.
    PLoS One. 2023;18:e0286334.
    >> Share

  55. NG AP, Chervu N, Sanaiha Y, Vadlakonda A, et al
    Sociodemographic disparities in concomitant left atrial appendage occlusion during cardiac valve operations.
    PLoS One. 2023;18:e0286337.
    >> Share

  56. WINSLOW U, Sakthivel T, Zheng C, Bosselmann H, et al
    Treatment-induced increase in total body potassium in patients at high risk of ventricular arrhythmias; a randomized POTCAST substudy.
    PLoS One. 2023;18:e0288756.
    >> Share

  57. HE J, Jiang Y, Xiao Y, Hao P, et al
    Effect of implantable cardiac monitors on preventing stroke: A systematic review and meta-analysis of randomized clinical trials.
    PLoS One. 2023;18:e0287318.
    >> Share

  58. KHATIB R, Glowacki N, Colavecchia C, Mills JR, et al
    Associations between clinical and social factors and anticoagulant prescription among patients with atrial fibrillation: A retrospective cohort study from a large healthcare system.
    PLoS One. 2023;18:e0289708.
    >> Share

  59. MAGTIBAY K, Masse S, Nanthakumar K, Umapathy K, et al
    Pro-arrhythmic role of adrenergic spatial densities in the human atria: An in-silico study.
    PLoS One. 2023;18:e0290676.
    >> Share

  60. RAMBARAT P, Zern EK, Wang D, Roshandelpoor A, et al
    Identifying high risk clinical phenogroups of pulmonary hypertension through a clustering analysis.
    PLoS One. 2023;18:e0290553.
    >> Share

  61. DOWNES M, Welters ID, Johnston BW
    Study protocol: A systematic review and meta-analysis regarding the influence of coagulopathy and immune activation on new onset atrial fibrillation in patients with sepsis.
    PLoS One. 2023;18:e0290963.
    >> Share

  62. EARLY PL, Kilcawley NA, McArdle NA, Renou M, et al
    Digital process control of multi-step assays on centrifugal platforms using high-low-high rotational-pulse triggered valving.
    PLoS One. 2023;18:e0291165.
    >> Share

  63. LIGERO C, Bazan V, Guerra JM, Rodriguez-Manero M, et al
    Influence of body mass index on recurrence of atrial fibrillation after electrical cardioversion.
    PLoS One. 2023;18:e0291938.
    >> Share

  64. QI M, Shao H, Shi N, Wang G, et al
    Arrhythmia classification detection based on multiple electrocardiograms databases.
    PLoS One. 2023;18:e0290995.
    >> Share

  65. TRINKS-ROERDINK EM, Geersing GJ, van den Dries CJ, Hemels MEW, et al
    Integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial.
    PLoS One. 2023;18:e0292586.
    >> Share

  66. ESFAHANI K, Tennant W, Tsang S, Naik BI, et al
    Comparison of oral versus intravenous methadone on postoperative pain and opioid use after adult spinal deformity surgery: A retrospective, non-inferiority analysis.
    PLoS One. 2023;18:e0288988.
    >> Share

  67. LIU C, Han S, Cui K, Wang F, et al
    Efficacy and safety of patients with chronic kidney disease undergoing left atrial appendage closure for atrial fibrillation.
    PLoS One. 2023;18:e0287928.
    >> Share

  68. CURRAN J, Ross-White A, Sibley S
    Magnesium prophylaxis of new-onset atrial fibrillation: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0292974.
    >> Share

  69. AMMAR L, Tindle HA, Miller AM, Adgent MA, et al
    Electronic cigarette use during pregnancy and the risk of adverse birth outcomes: A cross-sectional surveillance study of the US Pregnancy Risk Assessment Monitoring System (PRAMS) population.
    PLoS One. 2023;18:e0287348.
    >> Share

  70. AL-MAISARY S, Romano G, Karck M, De Simone R, et al
    Octogenarian patients and laser-assisted lead extraction: Should we put a limit?
    PLoS One. 2023;18:e0284802.
    >> Share

  71. GOULART AC, Varella AC, Gooden TE, Lip GYH, et al
    Identifying and understanding the care pathway of patients with atrial fibrillation in Brazil and the impact of the COVID-19 pandemic: A mixed-methods study.
    PLoS One. 2023;18:e0292463.
    >> Share

  72. SASANO T, Ihara K, Tanaka T, Furukawa T, et al
    Risk stratification of atrial fibrillation and stroke using single nucleotide polymorphism and circulating biomarkers.
    PLoS One. 2023;18:e0292118.
    >> Share

  73. RUSH KL, Seaton CL, Burton L, Loewen P, et al
    Quality of life among patients with atrial fibrillation: A theoretically-guided cross-sectional study.
    PLoS One. 2023;18:e0291575.
    >> Share

  74. WEN J, Ding X, Liu C, Jiang W, et al
    A comparation of dexmedetomidine and midazolam for sedation in patients with mechanical ventilation in ICU: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0294292.
    >> Share

  75. ZHOU Y, Sun C, Ma Y, Huang Y, et al
    Identification and validation of aging-related genes in atrial fibrillation.
    PLoS One. 2023;18:e0294282.
    >> Share

  76. MONTERO-BALOSA MC, Limon-Mora JA, Leal-Atienza A, Luque-Romero LG, et al
    Effectiveness and safety of oral anticoagulant therapy in a real-world cohort with atrial fibrillation: The SIESTA-A study protocol.
    PLoS One. 2023;18:e0294822.
    >> Share

  77. KOSTER LS, Zhu X, Smith CK, Aisa J, et al
    Single center retrospective clinical audit and comparison of outcome between epicardial and transvenous endocardial permanent pacemaker implantations in dogs.
    PLoS One. 2023;18:e0290029.
    >> Share

  78. ZHANG J, Nguyen AH, Jilani D, Trigo Torres RS, et al
    Consecutive treatments of methamphetamine promote the development of cardiac pathological symptoms in zebrafish.
    PLoS One. 2023;18:e0294322.
    >> Share

  79. TARNOVSKAYA SI, Kostareva AA, Zhorov BS
    In silico analysis of TRPM4 variants of unknown clinical significance.
    PLoS One. 2023;18:e0295974.
    >> Share

  80. LUNDSTROM A, Wiklund U, Winbo A, Eliasson H, et al
    Cardiac response to water activities in children with Long QT syndrome type 1.
    PLoS One. 2023;18:e0295431.
    >> Share

  81. LUSK JB, Wilson L, Nalwade V, Song A, et al
    Atrial fibrillation as a novel risk factor for retinal stroke: A protocol for a population-based retrospective cohort study.
    PLoS One. 2023;18:e0296251.
    >> Share

    January 2022
  82. FU F, Pietropaolo M, Cui L, Pandit S, et al
    Lack of authentic atrial fibrillation in commonly used murine atrial fibrillation models.
    PLoS One. 2022;17:e0256512.
    >> Share

  83. MOL D, Boersma AM, Berger WR, Khan M, et al
    Intermediate-term outcome of cryoballoon ablation of persistent atrial fibrillation and improvements in quality of life of patients.
    PLoS One. 2022;17:e0261841.
    >> Share

  84. CHRISTERSSON C, Held C, Modica A, Westerbergh J, et al
    Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation-A SWEDEHEART study.
    PLoS One. 2022;17:e0262580.
    >> Share

  85. REINHART JM, de Oliveira GAR, Forsythe L, Li Z, et al
    Pharmacokinetics of a 503B outsourcing facility-produced theophylline in dogs.
    PLoS One. 2022;17:e0262336.
    >> Share

  86. FASTNER C, Szabo K, Samartzi M, Kruska M, et al
    Treatment standards for direct oral anticoagulants in patients with acute ischemic stroke and non-valvular atrial fibrillation: A survey among German stroke units.
    PLoS One. 2022;17:e0264122.
    >> Share

  87. CHOI BJ, Koo Y, Kim TY, Lim HS, et al
    Data-driven drug-induced QT prolongation surveillance using adverse reaction signals derived from 12-lead and continuous electrocardiogram data.
    PLoS One. 2022;17:e0263117.
    >> Share

  88. LIU X, Liu H, Wang L, Zhang L, et al
    Role of sacubitril-valsartan in the prevention of atrial fibrillation occurrence in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2022;17:e0263131.
    >> Share

  89. CIMINATA G, Geue C, Wu O, Deidda M, et al
    Propensity score methods for comparative-effectiveness analysis: A case study of direct oral anticoagulants in the atrial fibrillation population.
    PLoS One. 2022;17:e0262293.
    >> Share

  90. NATHANIA J, Woo BFY, Cher BP, Toh KY, et al
    Patient perspectives of the Self-management and Educational Technology tool for Atrial Fibrillation (SETAF): A mixed-methods study in Singapore.
    PLoS One. 2022;17:e0262033.
    >> Share

  91. SONG J, Zhang Q, Ye L, Zheng Y, et al
    The comparison of catheter ablation on hard outcomes versus medical treatment for atrial fibrillation patients: A meta-analysis of randomized, controlled trials with trial sequential analysis.
    PLoS One. 2022;17:e0262702.
    >> Share

  92. MUNIR MB, Hlavacek P, Keshishian A, Guo JD, et al
    Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database.
    PLoS One. 2022;17:e0263903.
    >> Share

  93. MARTINEZ-CAMPELO L, Cruz R, Blanco-Verea A, Moscoso I, et al
    Searching for genetic modulators of the phenotypic heterogeneity in Brugada syndrome.
    PLoS One. 2022;17:e0263469.
    >> Share

  94. SHABBIR MA, Saad Shaukat MH, Ehtesham M, Murawski S, et al
    Bifascicular block in unexplained syncope is underrecognized and under-evaluated: A single-center audit of ESC guidelines adherence.
    PLoS One. 2022;17:e0263727.
    >> Share

  95. NASIMI F, Yazdchi M
    LDIAED: A lightweight deep learning algorithm implementable on automated external defibrillators.
    PLoS One. 2022;17:e0264405.
    >> Share

  96. RUSS D, Williams JA, Cardoso VR, Bravo-Merodio L, et al
    Evaluating the detection ability of a range of epistasis detection methods on simulated data for pure and impure epistatic models.
    PLoS One. 2022;17:e0263390.
    >> Share

  97. PARK J, Jung JH, Choi EK, Lee SW, et al
    Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    PLoS One. 2022;17:e0264538.
    >> Share

  98. IKOMA T, Naruse Y, Kaneko Y, Sakakibara T, et al
    Pre-procedural predictors of left atrial low-voltage zones in patients undergoing catheter ablation of atrial fibrillation.
    PLoS One. 2022;17:e0266939.
    >> Share

  99. OCAK G, Khairoun M, Khairoun O, Bos WJW, et al
    Chronic kidney disease and atrial fibrillation: A dangerous combination.
    PLoS One. 2022;17:e0266046.
    >> Share

  100. HIROSHI I, Natsuko SY, Yutaka I, Masayori S, et al
    Frequency of hemorrhage after tooth extraction in patients treated with a direct oral anticoagulant: A multicenter cross-sectional study.
    PLoS One. 2022;17:e0266011.
    >> Share

  101. MATSUNAGA-LEE Y, Egami Y, Matsumoto S, Masunaga N, et al
    Electrophysiological characteristics of non-pulmonary vein triggers excluding origins from the superior vena cava and left atrial posterior wall: Lessons from the self-reference mapping technique.
    PLoS One. 2022;17:e0263938.
    >> Share

  102. KOGE J, Yamagami H, Toyoda K, Yasaka M, et al
    Early initiation of rivaroxaban after reperfusion therapy for stroke patients with nonvalvular atrial fibrillation.
    PLoS One. 2022;17:e0264760.
    >> Share

  103. ESCOBAR CERVANTES C, Marti-Almor J, Cabeza AIP, Bowrin K, et al
    Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain.
    PLoS One. 2022;17:e0266658.
    >> Share

  104. NAKAI M, Iwanaga Y, Sumita Y, Wada S, et al
    Associations among cardiovascular and cerebrovascular diseases: Analysis of the nationwide claims-based JROAD-DPC dataset.
    PLoS One. 2022;17:e0264390.
    >> Share

  105. SAKAMOTO K, Mukai Y, Kawai S, Nagaoka K, et al
    Intra-atrial activation pattern is useful to localize the areas of non-pulmonary vein triggers of atrial fibrillation.
    PLoS One. 2022;17:e0264894.
    >> Share

  106. UHE T, Stegmann T, Langhammer R, Dagres N, et al
    Signs of left atrial disease and 10-year risk of atrial fibrillation.
    PLoS One. 2022;17:e0266848.
    >> Share

  107. BANERAS J, Pariggiano I, Rodenas-Alesina E, Oristrell G, et al
    Optimal opportunistic screening of atrial fibrillation using pulse palpation in cardiology outpatient clinics: Who and how.
    PLoS One. 2022;17:e0266955.
    >> Share

  108. WEI N, Tolkacheva EG
    Mechanisms of arrhythmia termination during acute myocardial ischemia: Role of ephaptic coupling and complex geometry of border zone.
    PLoS One. 2022;17:e0264570.
    >> Share

  109. ARNOLD R, Hofer E, Haas J, Sanchez-Quintana D, et al
    Diversity and complexity of the cavotricuspid isthmus in rabbits: A novel scheme for classification and geometrical transformation of anatomical structures.
    PLoS One. 2022;17:e0264625.
    >> Share

  110. YAMADA Y, Minatoguchi S, Baba S, Shibata S, et al
    Human Muse cells reduce myocardial infarct size and improve cardiac function without causing arrythmias in a swine model of acute myocardial infarction.
    PLoS One. 2022;17:e0265347.
    >> Share

  111. WATSON GM, Sutherland J, Lacey C, Bridgman PG, et al
    A randomised cross-over trial of QT response to hyperventilation-induced anxiety and diaphragmatic breathing in patients with stress cardiomyopathy and in control patients.
    PLoS One. 2022;17:e0265607.
    >> Share

  112. WANG Y, Han Z, Wang Y, Yan Y, et al
    Risk factors of sitting-induced tachycardia syndrome in children and adolescents.
    PLoS One. 2022;17:e0265364.
    >> Share

  113. ALONSO A, Alam AB, Kamel H, Subbian V, et al
    Epidemiology of atrial fibrillation in the All of Us Research Program.
    PLoS One. 2022;17:e0265498.
    >> Share

  114. SILAND JE, Geelhoed B, Roselli C, Wang B, et al
    Resting heart rate and incident atrial fibrillation: A stratified Mendelian randomization in the AFGen consortium.
    PLoS One. 2022;17:e0268768.
    >> Share

  115. IKEUCHI Y, Ochi H, Motoda C, Tokuyama T, et al
    Plasma MicroRNAs as noninvasive diagnostic biomarkers in patients with Brugada syndrome.
    PLoS One. 2022;17:e0261390.
    >> Share

  116. SENOO K, Yukawa A, Ohkura T, Shoji K, et al
    Screening for untreated atrial fibrillation in the elderly population: A community-based study.
    PLoS One. 2022;17:e0269506.
    >> Share

  117. JANG HJ, Lee D, Kim TH, Kim JS, et al
    Clinical outcomes of gastrointestinal bleeding management during anticoagulation therapy.
    PLoS One. 2022;17:e0269262.
    >> Share

  118. DING M, Li QF, Yin G, Liu JL, et al
    Effects of Drosophila melanogaster regular exercise and apolipoprotein B knockdown on abnormal heart rhythm induced by a high-fat diet.
    PLoS One. 2022;17:e0262471.
    >> Share

  119. SAMUEL JP, Wootton SH, Holder T, Molony D, et al
    A scoping review of randomized trials assessing the impact of n-of-1 trials on clinical outcomes.
    PLoS One. 2022;17:e0269387.
    >> Share

  120. EROGLU TE, Blom MT, Souverein PC, Yasmina A, et al
    Acetylsalicylic acid use is associated with reduced risk of out-of-hospital cardiac arrest in the general population: Real-world data from a population-based study.
    PLoS One. 2022;17:e0267016.
    >> Share

  121. KORNEJ J, Friedrich K, Schroeter ML, Witte AV, et al
    PR interval duration is associated with the presence of white matter hyperintensities: Insights from the epidemiologic LIFE-Adult Study.
    PLoS One. 2022;17:e0269815.
    >> Share

  122. MOON I, Go TH, Kim JY, Kang DR, et al
    Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve.
    PLoS One. 2022;17:e0268113.
    >> Share

  123. ROGERS JD, Higuera L, Rosemas SC, Cheng YJ, et al
    Diagnostic sensitivity and cost per diagnosis of ambulatory cardiac monitoring strategies in unexplained syncope patients.
    PLoS One. 2022;17:e0270398.
    >> Share

  124. FALKENBERG M, Coleman JA, Dobson S, Hickey DJ, et al
    Identifying locations susceptible to micro-anatomical reentry using a spatial network representation of atrial fibre maps.
    PLoS One. 2022;17:e0267166.
    >> Share

  125. DARVISHI A, Sadeghipour P, Darrudi A, Daroudi R, et al
    Cost-utility analysis of Cryoballoon ablation versus Radiofrequency ablation in the treatment of paroxysmal atrial fibrillation in Iran.
    PLoS One. 2022;17:e0270642.
    >> Share

  126. FARRAG NA, Thornhill RE, Prato FS, Skanes AC, et al
    Assessment of left atrial fibrosis progression in canines following rapid ventricular pacing using 3D late gadolinium enhanced CMR images.
    PLoS One. 2022;17:e0269592.
    >> Share

  127. MOKGOKONG R, Schnabel R, Witt H, Miller R, et al
    Performance of an electronic health record-based predictive model to identify patients with atrial fibrillation across countries.
    PLoS One. 2022;17:e0269867.
    >> Share

  128. BOUWMEESTER S, van Loon T, Ploeg M, Mast TP, et al
    Left atrial remodeling in mitral regurgitation: A combined experimental-computational study.
    PLoS One. 2022;17:e0271588.
    >> Share

  129. SU CH, Lo CH, Chen HH, Tsai CF, et al
    CHA2DS2-VASc score as an independent outcome predictor in patients hospitalized with acute ischemic stroke.
    PLoS One. 2022;17:e0270823.
    >> Share

  130. ZHU L, Marsh JW, Griffith MP, Collins K, et al
    Predictive model for severe COVID-19 using SARS-CoV-2 whole-genome sequencing and electronic health record data, March 2020-May 2021.
    PLoS One. 2022;17:e0271381.
    >> Share

  131. KABUS D, Arno L, Leenknegt L, Panfilov AV, et al
    Numerical methods for the detection of phase defect structures in excitable media.
    PLoS One. 2022;17:e0271351.
    >> Share

  132. NAKAJIMA T, Kawabata-Iwakawa R, Tamura S, Hasegawa H, et al
    Novel CACNA1C R511Q mutation, located in domain - linker, causes non-syndromic type-8 long QT syndrome.
    PLoS One. 2022;17:e0271796.
    >> Share

  133. CHOI JH, Park SJ, Park KM, Kim JS, et al
    Efficacy and safety of cryoballoon pulmonary vein isolation for paroxysmal and persistent atrial fibrillation: A comparison with radiofrequency ablation.
    PLoS One. 2022;17:e0265482.
    >> Share

  134. DUAN J, Wang Q, Zhang B, Liu C, et al
    Accurate detection of atrial fibrillation events with R-R intervals from ECG signals.
    PLoS One. 2022;17:e0271596.
    >> Share

  135. PRADELLA M, Anastasopoulos C, Yang S, Moor M, et al
    Associations between fully-automated, 3D-based functional analysis of the left atrium and classification schemes in atrial fibrillation.
    PLoS One. 2022;17:e0272011.
    >> Share

  136. PALA E, Bustamante A, Clua-Espuny JL, Acosta J, et al
    Blood-biomarkers and devices for atrial fibrillation screening: Lessons learned from the AFRICAT (Atrial Fibrillation Research In CATalonia) study.
    PLoS One. 2022;17:e0273571.
    >> Share

  137. AMAMI K, Yoshihisa A, Horikoshi Y, Yamada S, et al
    Utility of a novel wearable electrode embedded in an undershirt for electrocardiogram monitoring and detection of arrhythmias.
    PLoS One. 2022;17:e0273541.
    >> Share

  138. ALKHALFAN F, Gyftopoulos A, Chen YJ, Williams CH, et al
    Identifying genetic variants associated with the ICD10 (International Classification of Diseases10)-based diagnosis of cerebrovascular disease using a large-scale biomedical database.
    PLoS One. 2022;17:e0273217.
    >> Share

  139. DE MARCO F, Ferrucci F, Risi M, Tortora G, et al
    Classification of QRS complexes to detect Premature Ventricular Contraction using machine learning techniques.
    PLoS One. 2022;17:e0268555.
    >> Share

  140. CHANG YK, Fan HC, Lin CC, Wang YH, et al
    Association between atrial fibrillation and risk of end-stage renal disease among adults with diabetes mellitus.
    PLoS One. 2022;17:e0273646.
    >> Share

  141. GO MT, George AM, Tahsin B, Fogelfeld L, et al
    Tachycardia in hyperthyroidism: Not so common.
    PLoS One. 2022;17:e0273724.
    >> Share

  142. DE LUSIGNAN S, Hobbs FDR, Liyanage H, Sherlock J, et al
    Long term follow up of direct oral anticoagulants and warfarin therapy on stroke, with all-cause mortality as a competing risk, in people with atrial fibrillation: Sentinel network database study.
    PLoS One. 2022;17:e0265998.
    >> Share

  143. BORJESSON E, Svennblad B, Wisten A, Borjesson M, et al
    Symptoms and ECG changes precede sudden cardiac death in hypertrophic cardiomyopathy-A nationwide study among the young in Sweden.
    PLoS One. 2022;17:e0273567.
    >> Share

  144. KUMAR M A, Chakrapani A
    Classification of ECG signal using FFT based improved Alexnet classifier.
    PLoS One. 2022;17:e0274225.
    >> Share

  145. BEIER L, Lu S, Franca LR, Marler S, et al
    Evolution of antithrombotic therapy for patients with atrial fibrillation: The prospective global GLORIA-AF registry program.
    PLoS One. 2022;17:e0274237.
    >> Share

  146. LIU Y, Sun XX, Du WY, Chen TT, et al
    Intensive versus conservative glycemic control in patients undergoing coronary artery bypass graft surgery: A protocol for systematic review of randomised controlled trials.
    PLoS One. 2022;17:e0276228.
    >> Share

  147. CHOI SH, Kim M, Kim H, Kim DH, et al
    Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation.
    PLoS One. 2022;17:e0275103.
    >> Share

  148. TEPPO K, Jaakkola J, Langen VL, Biancari F, et al
    Rural-urban differences in the initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study.
    PLoS One. 2022;17:e0276612.
    >> Share

  149. CELIK E, Hokamp NG, Goertz L, Fehske W, et al
    Is there an association between left atrial outpouching structures and recurrence of atrial fibrillation after catheter ablation?
    PLoS One. 2022;17:e0276369.
    >> Share

  150. NA SJ, Yang JH, Ko RE, Chung CR, et al
    Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock.
    PLoS One. 2022;17:e0277087.
    >> Share

  151. TSAI HJ, Wong YS, Ong CT
    Clinical course and risk factors for sleep disturbance in patients with ischemic stroke.
    PLoS One. 2022;17:e0277309.
    >> Share

  152. TAKAYA Y, Nakayama R, Yokohama F, Toh N, et al
    Left atrial appendage morphology with the progression of atrial fibrillation.
    PLoS One. 2022;17:e0278172.
    >> Share

  153. WONG CK, Makalic E, Dite GS, Whiting L, et al
    Polygenic risk scores for cardiovascular diseases and type 2 diabetes.
    PLoS One. 2022;17:e0278764.
    >> Share

  154. CHATTOPADHYAY RK, Chousou PA, Mukherjee T, Pugh PJ, et al
    The predictive value of abnormal P-wave axis for the detection of incident atrial fibrillation: A systematic review with meta-analysis.
    PLoS One. 2022;17:e0278527.
    >> Share

  155. PERREAULT S, Cote R, Dragomir A, White-Guay B, et al
    Effectiveness and safety of low-dose versus standard-dose rivaroxaban and apixaban in patients with atrial fibrillation.
    PLoS One. 2022;17:e0277744.
    >> Share

  156. ATZEMA CL, Stiell IG, Chong AS, Austin PC, et al
    Validating emergency department cardioversion procedures in provincial administrative data in Ontario, Canada.
    PLoS One. 2022;17:e0277598.
    >> Share

  157. CORROCHANO M, Acosta-Isaac R, Plaza M, Munoz R, et al
    Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants.
    PLoS One. 2022;17:e0278693.
    >> Share

  158. NAGATA Y, Watanabe R, Eichhorn C, Ohno S, et al
    Targeted deep sequencing analyses of long QT syndrome in a Japanese population.
    PLoS One. 2022;17:e0277242.
    >> Share

  159. KAWAJI T, Shizuta S, Tanaka M, Nishiwaki S, et al
    Prognostic impact of catheter ablation in patients with asymptomatic atrial fibrillation.
    PLoS One. 2022;17:e0279178.
    >> Share

  160. ZENG Z, Wang Q, Yu Y, Zhang Y, et al
    Assessing electrocardiogram changes after ischemic stroke with artificial intelligence.
    PLoS One. 2022;17:e0279706.
    >> Share

  161. NAWAZ M, Ahmed J
    Cloud-based healthcare framework for real-time anomaly detection and classification of 1-D ECG signals.
    PLoS One. 2022;17:e0279305.
    >> Share

  162. MORI M, Zogg CK, Amabile A, Fereydooni S, et al
    Impact of secondary mitral regurgitation on survival in atrial and ventricular dysfunction.
    PLoS One. 2022;17:e0277385.
    >> Share

  163. TUTUKO B, Darmawahyuni A, Nurmaini S, Tondas AE, et al
    DAE-ConvBiLSTM: End-to-end learning single-lead electrocardiogram signal for heart abnormalities detection.
    PLoS One. 2022;17:e0277932.
    >> Share

    January 2021
  164. KOOK H, Kim HD, Shim J, Kim YH, et al
    Comparison of clinical outcomes between multiple antithrombotic therapy versus left atrial appendage occlusion with dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    PLoS One. 2021;16:e0244723.
    >> Share

  165. FINGROVA Z, Ambroz D, Jansa P, Kuchar J, et al
    The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension.
    PLoS One. 2021;16:e0245752.
    >> Share

  166. REZAEI-DARZI E, Mehdipour P, Di Cesare M, Farzadfar F, et al
    Evaluating equality in prescribing Novel Oral Anticoagulants (NOACs) in England: The protocol of a Bayesian small area analysis.
    PLoS One. 2021;16:e0246253.
    >> Share

  167. AREVALOS V, Ortega-Paz L, Fernandez-Rodriguez D, Alfonso Jimenez-Diaz V, et al
    Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol.
    PLoS One. 2021;16:e0255263.
    >> Share

  168. SILAND JE, Nguyen BO, de With RR, Van Gelder IC, et al
    Genetically-determined body mass index and the risk of atrial fibrillation progression in men and women.
    PLoS One. 2021;16:e0246907.
    >> Share

  169. SCHMIDT MM, Griffin JM, McCabe P, Stuart-Mullen L, et al
    Shared medical appointments: Translating research into practice for patients treated with ablation therapy for atrial fibrillation.
    PLoS One. 2021;16:e0246861.
    >> Share

  170. QAZI JZ, Schnitzer ME, Cote R, Martel MJ, et al
    Predicting major bleeding among hospitalized patients using oral anticoagulants for atrial fibrillation after discharge.
    PLoS One. 2021;16:e0246691.
    >> Share

  171. XIAOKERETI J, Guo YK, Dong ZY, Ma M, et al
    Enhanced atrial internal-external neural remodeling facilitates atrial fibrillation in the chronic obstructive sleep apnea model.
    PLoS One. 2021;16:e0247308.
    >> Share

  172. SHIYOVICH A, Chodick G, Azani L, Tirosh M, et al
    Sex-specific contemporary trends in incidence, prevalence and survival of patients with non-valvular atrial fibrillation: A long-term real-world data analysis.
    PLoS One. 2021;16:e0247097.
    >> Share

  173. DIMAI S, Semmler L, Prabhu A, Stachelscheid H, et al
    COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab.
    PLoS One. 2021;16:e0255976.
    >> Share

  174. CHAU E, Rosella LC, Mondor L, Wodchis WP, et al
    Association between continuity of care and subsequent diagnosis of multimorbidity in Ontario, Canada from 2001-2015: A retrospective cohort study.
    PLoS One. 2021;16:e0245193.
    >> Share

  175. MATUZ A, van der Linden D, Kisander Z, Hernadi I, et al
    Enhanced cardiac vagal tone in mental fatigue: Analysis of heart rate variability in Time-on-Task, recovery, and reactivity.
    PLoS One. 2021;16:e0238670.
    >> Share

  176. CHO SS, Jo SH, Kim HJ, Lee MH, et al
    Smoking may be more harmful to vasospastic angina patients who take antiplatelet agents due to the interaction: Results of Korean prospective multi-center cohort.
    PLoS One. 2021;16:e0248386.
    >> Share

  177. KOZIEL M, Teutsch C, Halperin JL, Rothman KJ, et al
    Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF.
    PLoS One. 2021;16:e0249524.
    >> Share

  178. LIN YC, Chen BL, Shih CM, Lin FY, et al
    Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study.
    PLoS One. 2021;16:e0249940.
    >> Share

  179. DE MARIA B, Dalla Vecchia LA, Maestri R, Pinna GD, et al
    Lack of association between heart period variability asymmetry and respiratory sinus arrhythmia in healthy and chronic heart failure individuals.
    PLoS One. 2021;16:e0247145.
    >> Share

  180. WENG S, Wang B, Li M, Chao S, et al
    Genome-wide association study of antipsychotic-induced sinus bradycardia in Chinese schizophrenia patients.
    PLoS One. 2021;16:e0249997.
    >> Share

  181. ABAD R, Collart O, Ganesan P, Rogers AJ, et al
    Three dimensional reconstruction to visualize atrial fibrillation activation patterns on curved atrial geometry.
    PLoS One. 2021;16:e0249873.
    >> Share

  182. GOMES FREITAS C, Walsh M, Coutinho EL, Vincenzo de Paola AA, et al
    Examining therapeutic equivalence between branded and generic warfarin in Brazil: The WARFA crossover randomized controlled trial.
    PLoS One. 2021;16:e0248567.
    >> Share

  183. ALAMMARI M, Sultana K, Alturaiki A, Thomas A, et al
    The development and validation of a multivariable model to predict the bleeding risk score for patients with non-valvular atrial fibrillation using direct oral anticoagulants in the Arab population.
    PLoS One. 2021;16:e0250502.
    >> Share

  184. RUFF C, Gerharz A, Groll A, Stoll F, et al
    Disease-dependent variations in the timing and causes of readmissions in Germany: A claims data analysis for six different conditions.
    PLoS One. 2021;16:e0250298.
    >> Share

  185. HAIDL H, Gaugler J, Cvirn G, Jasser-Nitsche H, et al
    Impact of electric cardioversion on platelet activation.
    PLoS One. 2021;16:e0250353.
    >> Share

  186. DHILLON GS, Ahluwalia N, Honarbakhsh S, Graham A, et al
    Impact of adenosine on mechanisms sustaining persistent atrial fibrillation: Analysis of contact electrograms and non-invasive ECGI mapping data.
    PLoS One. 2021;16:e0248951.
    >> Share

  187. JANG S, Ogunmoroti O, Zhao D, Fashanu OE, et al
    The association of novel inflammatory marker GlycA and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis (MESA).
    PLoS One. 2021;16:e0248644.
    >> Share

  188. RAVVAZ K, Weissert JA, Jahangir A, Ruff CT, et al
    Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillation.
    PLoS One. 2021;16:e0248134.
    >> Share

  189. CHUANG AM, Nguyen MT, Khan E, Jones D, et al
    Troponin elevation pattern and subsequent cardiac and non-cardiac outcomes: Implementing the Fourth Universal Definition of Myocardial Infarction and high-sensitivity troponin at a population level.
    PLoS One. 2021;16:e0248289.
    >> Share

  190. GARCHEVA V, Akin M, Adel J, Sanchez Martinez C, et al
    High rate of critical coronary stenosis in comatose patients with Non-ST-elevation out-of-hospital cardiac arrest (NSTE-OHCA) undergoing therapeutic hypothermia-Experience from the HAnnover COoling REgistry (HACORE).
    PLoS One. 2021;16:e0251178.
    >> Share

  191. YANASE T, Sakakura K, Jinnouchi H, Taniguchi Y, et al
    Factors associated with temporary pacing insertion in patients with inferior ST-segment elevation myocardial infarction.
    PLoS One. 2021;16:e0251124.
    >> Share

  192. ZAGIDULLIN NS, Motloch LJ, Musin TI, Bagmanova ZA, et al
    J-waves in acute COVID-19: A novel disease characteristic and predictor of mortality?
    PLoS One. 2021;16:e0257982.
    >> Share

  193. GUO A, Smith S, Khan YM, Langabeer Ii JR, et al
    Application of a time-series deep learning model to predict cardiac dysrhythmias in electronic health records.
    PLoS One. 2021;16:e0239007.
    >> Share

  194. SYOMIN F, Osepyan A, Tsaturyan A
    Computationally efficient model of myocardial electromechanics for multiscale simulations.
    PLoS One. 2021;16:e0255027.
    >> Share

  195. MASJEDI M, Jungen C, Kuklik P, Alken FA, et al
    A novel algorithm for 3-D visualization of electrogram duration for substrate-mapping in patients with ischemic heart disease and ventricular tachycardia.
    PLoS One. 2021;16:e0254683.
    >> Share

  196. REICHMANN-ARIEL D, Sadeh R, Galante O, Almog Y, et al
    Central venous catheter insertion- guidewire migration ratio: Right heart to inferior vena cava.
    PLoS One. 2021;16:e0252726.
    >> Share

  197. NASCIUTTI PR, Moraes AT, Santos TK, Goncalves Queiroz KK, et al
    Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C.
    PLoS One. 2021;16:e0254887.
    >> Share

  198. ROSENSTROM S, Risom SS, Ejlertsen C, Hove JD, et al
    Dancing with atrial fibrillation - How arrhythmia affects everyday life of family members: A qualitative study.
    PLoS One. 2021;16:e0254130.
    >> Share

  199. LIU XH, Xu Q, Luo T, Zhang L, et al
    Discontinuation of oral anticoagulation therapy after successful atrial fibrillation ablation: A systematic review and meta-analysis of prospective studies.
    PLoS One. 2021;16:e0253709.
    >> Share

  200. MALLADI CL, Darden D, Aldaas O, Mylavarapu PS, et al
    Association between specific antiarrhythmic drug prescription in the post-procedural blanking period and recurrent atrial arrhythmias after catheter ablation for atrial fibrillation.
    PLoS One. 2021;16:e0253266.
    >> Share

  201. SLAUGHTER MS, Monreal G, Koenig SC, Giridharan GA, et al
    Demonstration of proof-of-concept of StrokeShield system for complete closure and occlusion of the left atrial appendage for non-valvular atrial fibrillation therapy.
    PLoS One. 2021;16:e0253299.
    >> Share

  202. LEE HJ, Kim HK, Kim BS, Han KD, et al
    Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy.
    PLoS One. 2021;16:e0253310.
    >> Share

  203. WEFERLING M, Liebetrau C, Renker M, Fischer-Rasokat U, et al
    Right bundle branch block is not associated with worse short- and mid-term outcome after transcatheter aortic valve implantation.
    PLoS One. 2021;16:e0253332.
    >> Share

  204. HAMMER KP, Mustroph J, Stauber T, Birchmeier W, et al
    Beneficial effect of voluntary physical exercise in Plakophilin2 transgenic mice.
    PLoS One. 2021;16:e0252649.
    >> Share

  205. MISGANAW A, Sitote M, Jemal S, Melese E, et al
    Comparison of intravenous magnesium sulphate and lidocaine for attenuation of cardiovascular response to laryngoscopy and endotracheal intubation in elective surgical patients at Zewditu Memorial Hospital Addis Ababa, Ethiopia.
    PLoS One. 2021;16:e0252465.
    >> Share

  206. PALACIO LC, Pachajoa DC, Durango-Giraldo G, Zapata-Hernandez C, et al
    Atrial proarrhythmic effect of lead as one of the PM10 metal components of air pollution. An in-silico study.
    PLoS One. 2021;16:e0258313.
    >> Share

  207. KIM BJ, Lee KJ, Park EL, Tanaka K, et al
    Prediction of recurrent stroke among ischemic stroke patients with atrial fibrillation: Development and validation of a risk score model.
    PLoS One. 2021;16:e0258377.
    >> Share

  208. LANGE M, Hirahara AM, Ranjan R, Stoddard GJ, et al
    Atrial slow conduction develops and dynamically expands during premature stimulation in an animal model of persistent atrial fibrillation.
    PLoS One. 2021;16:e0258285.
    >> Share

  209. STEINHUBL SR, Waalen J, Sanyal A, Edwards AM, et al
    Three year clinical outcomes in a nationwide, observational, siteless clinical trial of atrial fibrillation screening-mHealth Screening to Prevent Strokes (mSToPS).
    PLoS One. 2021;16:e0258276.
    >> Share

  210. NIJPELS G, van der Heijden AAWA, Elders P, Beulens JWJ, et al
    The interobserver agreement of ECG abnormalities using Minnesota codes in people with type 2 diabetes.
    PLoS One. 2021;16:e0255466.
    >> Share

  211. CHO JH, Leong D, Cuk N, Ebinger JE, et al
    Delayed repolarization and ventricular tachycardia in patients with heart failure and preserved ejection fraction.
    PLoS One. 2021;16:e0254641.
    >> Share

  212. GARCIA-VILLAFRANCA A, Barrera-Lopez L, Pose-Bar M, Pardellas-Santiago E, et al
    De-novo non-convulsive status epilepticus in adult medical inpatients without known epilepsy: Analysis of mortality related factors and literature review.
    PLoS One. 2021;16:e0258602.
    >> Share

  213. PIAYDA K, Afzal S, Nielsen-Kudsk JE, Schmidt B, et al
    Length of stay following percutaneous left atrial appendage occlusion: Data from the prospective, multicenter Amplatzer Amulet Occluder Observational Study.
    PLoS One. 2021;16:e0255721.
    >> Share

  214. RIVOLO S, Di Fusco M, Polanco C, Kang A, et al
    Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain.
    PLoS One. 2021;16:e0259251.
    >> Share

  215. QIAN Y, Zhang J, Li J, Weng Z, et al
    A retrospective study on the evaluation of the appropriateness of oral anticoagulant therapy for patients with atrial fibrillation.
    PLoS One. 2021;16:e0259199.
    >> Share

  216. NEUBER JU, Pakhomov AG, Zemlin CW
    Electroporation safety factor of 300 nanosecond and 10 millisecond defibrillation in Langendorff-perfused rabbit hearts.
    PLoS One. 2021;16:e0257287.
    >> Share

  217. CANNAVAN PMS, Cannavan FPS, Oliveira HC, Walfridsson U, et al
    A Brazilian Portuguese translation, cultural adaptation and validation of the Arrhythmia-Specific questionnaire in Tachycardia and Arrhythmia (ASTA) health-related quality of life (HRQOL) scale.
    PLoS One. 2021;16:e0256851.
    >> Share

  218. XIAO J, Zhang Y, Tang Y, Dai H, et al
    MiRNA-1202 promotes the TGF-beta1-induced proliferation, differentiation and collagen production of cardiac fibroblasts by targeting nNOS.
    PLoS One. 2021;16:e0256066.
    >> Share

  219. REINHARDT SW, Desai NR, Tang Y, Jones PG, et al
    Personalizing the decision of dabigatran versus warfarin in atrial fibrillation: A secondary analysis of the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) trial.
    PLoS One. 2021;16:e0256338.
    >> Share

  220. LANKESTER J, Zanetti D, Ingelsson E, Assimes TL, et al
    Alcohol use and cardiometabolic risk in the UK Biobank: A Mendelian randomization study.
    PLoS One. 2021;16:e0255801.
    >> Share

  221. KIM IS, Choi YJ, Choi EY, Min PK, et al
    Comparison of risk profiles for new-onset atrial fibrillation between patients aged <60 and >/=60 years.
    PLoS One. 2021;16:e0258770.
    >> Share

  222. BAHRAMI RAD A, Galloway C, Treiman D, Xue J, et al
    Atrial fibrillation detection in outpatient electrocardiogram monitoring: An algorithmic crowdsourcing approach.
    PLoS One. 2021;16:e0259916.
    >> Share

  223. NAM KW, Kwon HM, Lee YS
    Effects of intracranial atherosclerosis and atrial fibrillation on the prognosis of ischemic stroke with active cancer.
    PLoS One. 2021;16:e0259627.
    >> Share

  224. WATANABE K, Nagata Y, Nitta G, Okata S, et al
    Impact of the sinus node recovery time after termination of atrial fibrillation during catheter ablation on clinical outcomes in patients with persistent atrial fibrillation.
    PLoS One. 2021;16:e0259750.
    >> Share

  225. YANAGISAWA D, Abe K, Amano H, Komatsuda S, et al
    Thrombotic events and rebleeding after hemorrhage in patients taking direct oral anticoagulants for non-valvular atrial fibrillation.
    PLoS One. 2021;16:e0260585.
    >> Share

  226. STRUPPEK J, Schnabel RB, Walther C, Heydecke G, et al
    Periodontitis, dental plaque, and atrial fibrillation in the Hamburg City Health Study.
    PLoS One. 2021;16:e0259652.
    >> Share

  227. MOTOC A, Luchian ML, Scheirlynck E, Roosens B, et al
    Incremental value of left atrial strain to predict atrial fibrillation recurrence after cryoballoon ablation.
    PLoS One. 2021;16:e0259999.
    >> Share

  228. SUBA S, Fleischmann KE, Schell-Chaple H, Prasad P, et al
    Diagnostic and prognostic significance of premature ventricular complexes in community and hospital-based participants: A scoping review.
    PLoS One. 2021;16:e0261712.
    >> Share

  229. SAGER S, Bernhardt F, Kehrle F, Merkert M, et al
    Expert-enhanced machine learning for cardiac arrhythmia classification.
    PLoS One. 2021;16:e0261571.
    >> Share

  230. YOSHIKAWA M, Asaba K, Nakayama T
    Causal effect of atrial fibrillation/flutter on chronic kidney disease: A bidirectional two-sample Mendelian randomization study.
    PLoS One. 2021;16:e0261020.
    >> Share

  231. LIU HT, Yang CH, Lee HL, Chang PC, et al
    Clinical Outcomes of low-voltage area-guided left atrial linear ablation for non-paroxysmal atrial fibrillation patients.
    PLoS One. 2021;16:e0260834.
    >> Share

  232. JANG JH, Kim TY, Lim HS, Yoon D, et al
    Unsupervised feature learning for electrocardiogram data using the convolutional variational autoencoder.
    PLoS One. 2021;16:e0260612.
    >> Share

  233. PATON MF, Gierula J, Lowry JE, Cairns DA, et al
    Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trial.
    PLoS One. 2021;16:e0259450.
    >> Share

  234. ANDERSON K, Bavishi C, Kolte D, Gohh R, et al
    Relation of abnormal cardiac stress testing with outcomes in patients undergoing renal transplantation.
    PLoS One. 2021;16:e0260718.
    >> Share

  235. KUFNER A, Ali HF, Ebinger M, Fiebach JB, et al
    The smoking paradox in ischemic stroke patients treated with intra-arterial thrombolysis in combination with mechanical thrombectomy-VISTA-Endovascular.
    PLoS One. 2021;16:e0251888.
    >> Share

  236. IKEDA T, Ogawa S, Kitazono T, Nakagawara J, et al
    Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS.
    PLoS One. 2021;16:e0251325.
    >> Share

  237. SU MI, Liu CW
    Neutrophil-to-lymphocyte ratio associated with an increased risk of mortality in patients with critical limb ischemia.
    PLoS One. 2021;16:e0252030.
    >> Share

  238. LO CH, Wang YH, Tsai CF, Chan KC, et al
    Association of hydroxychloroquine and cardiac arrhythmia in patients with systemic lupus erythematosus: A population-based case control study.
    PLoS One. 2021;16:e0251918.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016